Clarus Therapeutics Holdings Overview

Clarus Therapeutics Holdings Operating Income

Operating Income for CRXT.

Quarterly Operating Income

$-8674000.00

↓ 34.48% YoY

As of Jun 30, 2022

Annual Operating Income (TTM)

$-43174000.00

↑ 96.33% YoY

Trailing 12 months ending Jun 30, 2022

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin